Account

Table 2 The hepatorenal function of mice treated with PEG-PCCL (mean ± SD, n = 2)

From: Toxicity Assessment of PEG-PCCL Nanoparticles and Preliminary Investigation on Its Anti-tumor Effect of Paclitaxel-Loading

Samples	AST (U/L)	ALT (U/L)	ALP (U/L)	Albumin (g/L)	Creatinine (μmol/L)	Uric acid (μmol/L)
NS	17.50 ± 3.54	4.00 ± 0.00	23.00 ± 9.90	6.35 ± 0.07	5.50 ± 0.71	15.50 ± 6.36
PEG-PCCL	13.50 ± 0.71	5.00 ± 0.00	20.50 ± 7.78	4.75 ± 0.35	2.00 ± 0.00	18.00 ± 7.07

Note: data were collected 7 days after the administration of PEG-PCCL

Back to article page